Vermeer-de Bondt Patricia E, Dzaferagić Aida, David Silke, van der Maas Nicoline A T
Safety Surveillance and Consultation of the National Vaccination Programme, Centre for Infectious Disease Control, RIVM National Institute for Public Health and Environment, PO Box 1, 3720BA Bilthoven, The Netherlands.
Vaccine. 2006 Nov 30;24(49-50):7066-70. doi: 10.1016/j.vaccine.2006.07.008. Epub 2006 Jul 24.
We reviewed collapse (sudden onset of pallor, limpness and hyporesponsiveness) following the first infant (DPTP+Hib) vaccination reported to the enhanced passive surveillance system of the Netherlands in 1994-2003. All 1303 reports identified by the current RIVM (National Institute for Public Health and Environment) case definition were captured by the Brighton Collaboration (BC) case definition, with in 17 (1.3%) reports insufficient information. Over the years the proportion of the highest level of diagnostic certainty (level 1) increased due to more complete data from 70% to over 90%. We checked the BC case definition also on a sample of cases (with pallor or hyporesponsiveness) not meeting RIVM's case definition for collapse at the time. Sixty out of 200 cases were captured by BC but again rejected by RIVM. The sensitivity BC levels 2 and 3 appeared too high. We recommend a more restrict case definition by the Brighton Collaboration with certain exclusion criteria to make it more specific. Furthermore a change in the specifications for levels 2 and 3 will increase specificity and accommodate for the loss of sensitivity.
我们回顾了1994年至2003年向荷兰强化被动监测系统报告的首例婴儿接种白喉、破伤风、百日咳和 Hib 联合疫苗(DPTP+Hib)后出现虚脱(突然面色苍白、软弱无力和反应低下)的情况。当前荷兰国家公共卫生和环境研究所(RIVM)的病例定义所识别的所有1303份报告均被纳入布莱顿协作组织(BC)的病例定义,其中17份(1.3%)报告信息不足。多年来,由于数据更完整,最高诊断确定性水平(1级)的比例从70%增加到了90%以上。我们还对当时不符合RIVM虚脱病例定义的病例样本(有面色苍白或反应低下症状)进行了BC病例定义的检查。200例病例中有60例被BC纳入,但再次被RIVM排除。BC的2级和3级病例定义的敏感性似乎过高。我们建议布莱顿协作组织采用更严格的病例定义,并设定某些排除标准,使其更具特异性。此外,对2级和3级病例定义的规范进行修改将提高特异性,并弥补敏感性的损失。